AXIM Biotech to Present at 6th Annual SeeThruEquity Microcap Investor Conference in New York City
June 01, 2017 09:30 ET
|
AXIM Biotechnologies, Inc
NEW YORK, June 01, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George Anastassov,...
CURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting Cannabinoids
May 31, 2017 09:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., May 31, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development...
AXIM Biotech to Present Research Abstracts at the 6th Pharmaceutical Sciences World Congress
May 23, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, May 23, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that Lekhram Changoer,...
SeeThruEquity Initiates Coverage on AXIM® Biotechnologies (OTC: AXIM) With a Target Price of $17.0
May 16, 2017 10:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, May 16, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that SeeThruEquity, a...
SeeThruEquity Initiates Coverage on AXIM® Biotech (OTC: AXIM) With a Target Price of $17.0
May 16, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, May 16, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that SeeThruEquity, a...
AXIM Biotech Clinical Study to Develop Bioequivalent Product to Marinol Listed on Clinicaltrials.gov
May 15, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, May 15, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that information on the...
CURE Pharmaceutical Announces Entrance Into Booming Pharmaceutical Cannabis Industry
May 10, 2017 09:00 ET
|
CURE Pharmaceutical
Oxnard, Calif., May 10, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching and developing drug and...
CURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate Development
May 09, 2017 09:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching cannabinoid molecules for various...
AXIM® Biotech Expands Advisory Board With Oncology Specialist and Medicinal Cannabis Leading Expert – Dr. Donald Abrams
May 09, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, May 09, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced the addition to its...
CURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of Directors
May 03, 2017 09:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., May 03, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching cannabinoid molecules for various...